Lekarna.cz

Lekarna.cz's net profit fell 546% yoy to CZK -8.17 mil in 2018

By Helgi Analytics - May 6, 2020

Lekarna.cz made a net profit of CZK -8.17 mil with revenues of CZK 519 mil in 2018, down by 546% and up by 1.64%, r...

Lekarna.cz's employees rose 2.22% yoy to 92.0 in 2018

By Helgi Analytics - May 6, 2020

Lekarna.cz employed 92.0 employees in 2018, up 2.22% compared to the previous year. Historically, between 2010 and 2018...

Lekarna.cz's ROCE fell 492% yoy to -16.7% in 2018

By Helgi Analytics - May 6, 2020

Lekarna.cz made a net profit of CZK -8.17 mil in 2018, down 546% compared to the previous year. Historically, between 2006 a...

Profit Statement 2016 2017 2018
Sales 522 510 519
Gross Profit CZK mil 145 136 136
EBITDA 8.46 6.09 9.55
EBIT 7.11 4.03 5.56
Financing Cost CZK mil 0.483 0.517 1.18
Pre-Tax Profit CZK mil 4.82 1.99 -7.56
Net Profit CZK mil 3.24 1.83 -8.17
Balance Sheet 2016 2017 2018
Total Assets CZK mil 125 138 127
Non-Current Assets CZK mil 11.1 12.2 21.4
Current Assets CZK mil 109 120 113
Working Capital CZK mil 24.9 37.9 26.4
Shareholders' Equity CZK mil 125 31.8 23.5
Liabilities CZK mil 0 106 104
Total Debt CZK mil 31.6 49.4 52.6
Net Debt CZK mil 6.38 25.3 25.7
Ratios 2016 2017 2018
ROE % 2.59 2.33 -29.5
ROCE % 9.89 4.25 -16.7
Gross Margin % 27.7 26.6 26.3
EBITDA Margin % 1.62 1.19 1.84
EBIT Margin % 1.36 0.789 1.07
Net Margin % 0.620 0.359 -1.57
Net Debt/EBITDA 0.754 4.15 2.69
Net Debt/Equity % 5.10 79.5 109
Cost of Financing % 1.54 1.28 2.31
Cash Flow 2016 2017 2018
Total Cash From Operations CZK mil -0.562 -13.0 4.11
Total Cash From Investing CZK mil -3.75 0.109 -3.86
Total Cash From Financing CZK mil 0.201 11.7 2.60
Net Change In Cash CZK mil -4.11 -1.11 2.85
Cash Conversion Cycle days 11.7 24.2 12.7
Cash Earnings CZK mil 4.59 3.90 -4.18
Free Cash Flow CZK mil -4.31 -12.8 0.249

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
income statement                          
Sales             428 499 549 474 522    
Gross Profit CZK mil             129 135 148 137 145    
EBIT             1.32 -14.0 -16.6 14.6 7.11    
Net Profit CZK mil             -1.98 -15.4 -5.08 10.5 3.24    
                             
ROE % ...           -3.58 -37.8 -20.8 14.3 2.59    
EBIT Margin %             0.308 -2.81 -3.02 3.09 1.36    
Net Margin %             -0.461 -3.08 -0.926 2.21 0.620    
Employees ... ... ... ...     110 125 130 86.0 83.6    
balance sheet                          
Total Assets CZK mil             149 139 86.7 125 125    
Non-Current Assets CZK mil             14.9 16.5 7.40 8.64 11.1    
Current Assets CZK mil             133 122 79.1 116 109    
                             
Shareholders' Equity CZK mil             53.7 27.6 21.3 125 125    
Liabilities CZK mil             95.4 112 65.4 0 0    
Non-Current Liabilities CZK mil             0 0 0 0 0    
Current Liabilities CZK mil             77.8 78.6 53.2 86.4 79.1    
                             
Net Debt/EBITDA             -1.82 0.312 -0.202 0.115 0.754    
Net Debt/Equity %             -10.3 -13.9 14.6 1.42 5.10    
Cost of Financing % ... ... ... ... ... ... 2.39 2.08 2.87 2.72 1.54    
cash flow                          
Total Cash From Operations CZK mil ... ... ... ... ... ... ... ... ... ... -0.562    
Total Cash From Investing CZK mil ... ... ... ... ... ... ... ... ... ... -3.75    
Total Cash From Financing CZK mil ... ... ... ... ... ... ... ... ... ... 0.201    
Net Change In Cash CZK mil ... ... ... ... ... ... ... ... ... ... -4.11    
income statement Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
income statement                          
Sales             428 499 549 474 522    
Cost of Goods & Services CZK mil             300 364 401 337 377    
Gross Profit CZK mil             129 135 148 137 145    
Staff Cost CZK mil             52.0 59.8 64.1 45.3 44.6    
EBITDA             3.04 -12.3 -15.4 15.4 8.46    
Depreciation CZK mil             1.72 1.73 1.19 0.770 1.35    
EBIT             1.32 -14.0 -16.6 14.6 7.11    
Net Financing Cost CZK mil             1.91 1.22 2.39 1.43 2.29    
Financing Cost CZK mil             0.209 0.449 0.513 0.559 0.483    
Financing Income CZK mil             0.006 0.025 0.033 0.207 0.080    
Pre-Tax Profit CZK mil             -1.87 -15.4 -4.66 13.2 4.82    
Tax CZK mil             0.109 0 0.420 2.73 1.59    
Minorities CZK mil             0 0 0 0 0    
Net Profit CZK mil             -1.98 -15.4 -5.08 10.5 3.24    
Net Profit Avail. to Common CZK mil             -1.98 -15.4 -5.08 10.5 3.24    
growth rates                          
Total Revenue Growth % ...           19.1 16.5 9.96 -13.7 10.1    
Staff Cost Growth % ...           37.6 15.0 7.15 -29.3 -1.57    
EBITDA Growth % ...           -85.8 -504 25.2 -200 -45.1    
EBIT Growth % ...           -93.5 -1,162 18.2 -188 -51.4    
Pre-Tax Profit Growth % ...           -110 723 -69.7 -383 -63.5    
Net Profit Growth % ...           -113 678 -66.9 -306 -69.1    
ratios                          
ROE % ...           -3.58 -37.8 -20.8 14.3 2.59    
ROA % ...           -1.55 -10.7 -4.50 9.89 2.59    
ROCE % ...           -4.29 -26.8 -12.0 36.3 9.89    
Gross Margin %             30.1 27.0 27.0 28.9 27.7    
EBITDA Margin %             0.710 -2.46 -2.80 3.25 1.62    
EBIT Margin %             0.308 -2.81 -3.02 3.09 1.36    
Net Margin %             -0.461 -3.08 -0.926 2.21 0.620    
Cost of Financing % ... ... ... ... ... ... 2.39 2.08 2.87 2.72 1.54    
Net Debt/EBITDA             -1.82 0.312 -0.202 0.115 0.754    
balance sheet Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
balance sheet                          
Cash & Cash Equivalents CZK mil             23.0 29.5 6.90 29.3 25.2    
Receivables CZK mil             56.5 47.4 41.3 43.6 46.2    
Inventories CZK mil             37.2 30.1 14.9 23.1 19.3    
Current Assets CZK mil             133 122 79.1 116 109    
Property, Plant & Equipment CZK mil             9.13 11.1 1.20 1.81 0.878    
LT Investments & Receivables CZK mil             0 0 0 0 0    
Intangible Assets CZK mil             0.909 0.536 2.40 4.48 7.48    
Goodwill CZK mil             0 0 0 0 0    
Non-Current Assets CZK mil             14.9 16.5 7.40 8.64 11.1    
Total Assets CZK mil             149 139 86.7 125 125    
                             
Trade Payables CZK mil             50.4 37.5 35.3 46.0 40.5    
Short-Term Debt CZK mil             17.5 25.7 10.0 31.1 31.6    
Current Liabilities CZK mil             77.8 78.6 53.2 86.4 79.1    
Long-Term Debt CZK mil             0 0 0 0 0    
Other LT Liabilities CZK mil             0 0 0 0 0    
Non-Current Liabilities CZK mil             0 0 0 0 0    
Liabilities CZK mil             95.4 112 65.4 0 0    
Equity Before Minority Interest CZK mil             53.7 27.6 21.3 125 125    
Minority Interest CZK mil             0 0 0 0 0    
Equity CZK mil             53.7 27.6 21.3 125 125    
growth rates                          
Total Asset Growth % ...           41.4 -6.61 -37.7 44.2 0.097    
Shareholders' Equity Growth % ...           -5.48 -48.5 -22.9 487 0.097    
Net Debt Growth % ...           -82.2 -30.6 -181 -42.7 259    
Total Debt Growth % ... ... ... ... ... ... ... 46.9 -61.1 211 1.58    
ratios                          
Total Debt CZK mil             17.5 25.7 10.0 31.1 31.6    
Net Debt CZK mil             -5.53 -3.83 3.10 1.78 6.38    
Working Capital CZK mil             43.3 40.1 20.9 20.7 24.9    
Capital Employed CZK mil             58.2 56.6 28.3 29.4 36.0    
Net Debt/Equity %             -10.3 -13.9 14.6 1.42 5.10    
Current Ratio             1.71 1.55 1.49 1.34 1.38    
Quick Ratio             1.02 0.979 0.905 0.844 0.902    
cash flow Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
cash flow                          
Net Profit CZK mil             -1.98 -15.4 -5.08 10.5 3.24    
Depreciation CZK mil             1.72 1.73 1.19 0.770 1.35    
Non-Cash Items CZK mil ... ... ... ... ... ... ... ... ... ... -0.962    
Change in Working Capital CZK mil ... ... ... ... ... ... ... ... ... ... -4.19    
Total Cash From Operations CZK mil ... ... ... ... ... ... ... ... ... ... -0.562    
                             
Capital Expenditures CZK mil ... ... ... ... ... ... ... ... ... ... -3.85    
Other Investing Activities CZK mil ... ... ... ... ... ... ... ... ... ... 0.099    
Total Cash From Investing CZK mil ... ... ... ... ... ... ... ... ... ... -3.75    
                             
Dividends Paid CZK mil ... ... ... ... ... ... ... ... ... ... 0    
Issuance Of Shares CZK mil ... ... ... ... ... ... ... ... ... ... 0    
Issuance Of Debt CZK mil ... ... ... ... ... ... ... ... ... ... 0.490    
Total Cash From Financing CZK mil ... ... ... ... ... ... ... ... ... ... 0.201    
                             
Effect of FX Rates CZK mil ... ... ... ... ... ... ... ... ... ... ...    
Net Change In Cash CZK mil ... ... ... ... ... ... ... ... ... ... -4.11    
ratios                          
Days Sales Outstanding days             48.1 34.7 27.4 33.6 32.3    
Days Sales Of Inventory days             45.3 30.2 13.6 25.0 18.6    
Days Payable Outstanding days             61.4 37.5 32.2 49.8 39.2    
Cash Conversion Cycle days             32.0 27.3 8.88 8.83 11.7    
Cash Earnings CZK mil             -0.256 -13.6 -3.89 11.2 4.59    
Free Cash Flow CZK mil ... ... ... ... ... ... ... ... ... ... -4.31    
Capital Expenditures (As % of Sales) % ... ... ... ... ... ... ... ... ... ... 0.738    
other ratios Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
                           
Employees ... ... ... ...     110 125 130 86.0 83.6    
Cost Per Employee USD per month ... ... ... ...     2,015 2,039 1,923 1,840 1,763    
Cost Per Employee (Local Currency) CZK per month ... ... ... ...     39,410 39,891 41,097 43,913 44,471    
Staff Cost (As % of Sales) %             12.1 12.0 11.7 9.56 8.55    
Effective Tax Rate %             -5.84 0 -9.01 20.7 32.9    
Total Revenue Growth (5-year average) % ... ... ... ... ...   23.8 18.8 17.2 10.4 7.72    
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ... 18.7    

Get all company financials in excel:

Download Sample   $19.99

Lekarna.cz's Net Margin fell 539% yoy to -1.57% in 2018

By Helgi Analytics - May 6, 2020

Lekarna.cz made a net profit of CZK -8.17 mil with revenues of CZK 519 mil in 2018, down by 546% and up by 1.64%, respectively, compared to the previous year. This translates into a net margin of -1.57%. Historically, between 2006 and 2018, the firm...

Lekarna.cz's Net Debt/EBITDA fell 35.2% yoy to 2.69 in 2018

By Helgi Analytics - May 6, 2020

Lekarna.cz's net debt stood at CZK 25.7 mil and accounted for 109% of equity at the end of 2018. The ratio is up 29.9 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 109% in 2018 and a low of -8...

More News

Lekarna.cz is a Czech-based online pharmacy owned by Pears Health Cyber. The Company was set up by Vladimír Finsterle in 1999 as an information portal about medications. In 2003, the Company turned into an e-shop and become the first online pharmacy in the Czech Republic.

Lekarna.cz Logo

Finance

Lekarna.cz has been growing its sales by 0.771% a year on average in the last 5 years. EBITDA has grown by 178% during that time to total of 9.55 in 2018, or 1.84% of sales. That’s compared to 1.02% average margin seen in last five years.

The company netted CZK -8.17 mil in 2018 implying ROE of -29.5% and ROCE of -16.7%. Again, the average figures were -6.22% and 4.36%, respectively when looking at the previous 5 years.

Lekarna.cz’s net debt amounted to CZK 25.7 mil at the end of 2018, or 109% of equity. When compared to EBITDA, net debt was 2.69x, up when compared to average of 1.50x seen in the last 5 years.